These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 26319336)

  • 21. The short-term effect on restenosis and thrombosis of a cobalt-chromium stent eluting two drugs in a porcine coronary artery model.
    Huang Y; Venkatraman SS; Boey FY; Umashankar PR; Mohanty M; Arumugam S
    J Interv Cardiol; 2009 Oct; 22(5):466-78. PubMed ID: 19627432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro blood and vascular compatibility of sirolimus-eluting organic/inorganic hybrid stent coatings.
    Jang TS; Cheon KH; Ahn JH; Song EH; Kim HE; Jung HD
    Colloids Surf B Biointerfaces; 2019 Jul; 179():405-413. PubMed ID: 30999119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term stability of self-assembled monolayers on electropolished L605 cobalt chromium alloy for stent applications.
    Kaufmann C; Mani G; Marton D; Johnson D; Agrawal CM
    J Biomed Mater Res B Appl Biomater; 2011 Aug; 98(2):280-9. PubMed ID: 21604365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-eluting coating of ginsenoside Rg1 and Re incorporated poly(lactic-co-glycolic acid) on stainless steel 316L: Physicochemical and drug release analyses.
    Miswan Z; Lukman SK; Abd Majid FA; Loke MF; Saidin S; Hermawan H
    Int J Pharm; 2016 Dec; 515(1-2):460-466. PubMed ID: 27793709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of Polymeric Prodrug Paclitaxel-Poly(lactic acid)-b-Polyisobutylene and Its Application in Coatings of a Drug Eluting Stent.
    Ren K; Zhang M; He J; Wu Y; Ni P
    ACS Appl Mater Interfaces; 2015 Jun; 7(21):11263-71. PubMed ID: 25955234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surface characterization of poly(lactic acid)/everolimus and poly(ethylene vinyl alcohol)/everolimus stents.
    Wu M; Kleiner L; Tang FW; Hossainy S; Davies MC; Roberts CJ
    Drug Deliv; 2010 Aug; 17(6):376-84. PubMed ID: 20373889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The behavior of vascular smooth muscle cells and platelets onto epigallocatechin gallate-releasing poly(l-lactide-co-epsilon-caprolactone) as stent-coating materials.
    Cho HH; Han DW; Matsumura K; Tsutsumi S; Hyon SH
    Biomaterials; 2008 Mar; 29(7):884-93. PubMed ID: 18031806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An investigation of adhesion in drug-eluting stent layers.
    Wolf KV; Zong Z; Meng J; Orana A; Rahbar N; Balss KM; Papandreou G; Maryanoff CA; Soboyejo W
    J Biomed Mater Res A; 2008 Oct; 87(1):272-81. PubMed ID: 18306306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular response and mechanical integrity of the new biodegradable polymer coated sirolimus-eluting PROLIM stent implanted in porcine coronary arteries.
    Milewski K; Gorycki B; Buszman PP; Jelonek M; Beaudry D; Lapointe JM; Guy LG; Abusamra M; Pająk J; Kinasz W; Wojakowski W; Leclerc G; Gil RJ; Buszman PE
    Kardiol Pol; 2012; 70(7):703-11. PubMed ID: 22825946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Nuclear Magnetic Resonance Spectroscopy as a Method for Evaluation of In Vivo Poly-l-Lactide Biodegradation Kinetics From Stent-Polymer Matrices: An Experimental Study Utilizing Porcine Model of In-Stent Restenosis.
    Orlik B; Buszman PP; Krauze A; Gąsior P; Desperak P; Pająk J; Kasperczyk J; Janas A; Jelonek M; Handzlik-Orlik G; Buszman PE; Milewski K
    J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):93-9. PubMed ID: 25944843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of cobalt chromium alloy based sirolimus-eluting stent with bioabsorbable polymer in porcine model.
    Wu YZ; Shen L; Wang QB; Hu X; Xie J; Qian JY; Ge JB
    Chin Med J (Engl); 2012 Mar; 125(6):983-9. PubMed ID: 22613518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and in vitro release profiles of drug-eluting controlled biodegradable polymer coating stents.
    Pan CJ; Tang JJ; Weng YJ; Wang J; Huang N
    Colloids Surf B Biointerfaces; 2009 Oct; 73(2):199-206. PubMed ID: 19541460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mussel inspired coating of a biocompatible cyclodextrin based polymer onto CoCr vascular stents.
    Sobocinski J; Laure W; Taha M; Courcot E; Chai F; Simon N; Addad A; Martel B; Haulon S; Woisel P; Blanchemain N; Lyskawa J
    ACS Appl Mater Interfaces; 2014 Mar; 6(5):3575-86. PubMed ID: 24533838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surface Modification of Biodegradable Polymers towards Better Biocompatibility and Lower Thrombogenicity.
    Rudolph A; Teske M; Illner S; Kiefel V; Sternberg K; Grabow N; Wree A; Hovakimyan M
    PLoS One; 2015; 10(12):e0142075. PubMed ID: 26641662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beneficial Effects of a Novel Bioabsorbable Polymer Coating on Enhanced Coronary Vasoconstricting Responses After Drug-Eluting Stent Implantation in Pigs in Vivo.
    Nishimiya K; Matsumoto Y; Uzuka H; Ogata T; Hirano M; Shindo T; Hasebe Y; Tsuburaya R; Shiroto T; Takahashi J; Ito K; Shimokawa H
    JACC Cardiovasc Interv; 2016 Feb; 9(3):281-291. PubMed ID: 26847120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
    Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug eluting stents based on Poly(ethylene carbonate): optimization of the stent coating process.
    Bege N; Steinmüller SO; Kalinowski M; Reul R; Klaus S; Petersen H; Curdy C; Janek J; Kissel T
    Eur J Pharm Biopharm; 2012 Apr; 80(3):562-70. PubMed ID: 22209978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Supralimus sirolimus-eluting stent.
    Lemos PA; Bienert I
    Expert Rev Med Devices; 2013 May; 10(3):295-300. PubMed ID: 23597097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein release from water-swellable poly(D,L-lactide-PEG)-b-poly(ϵ-caprolactone) implants.
    Stanković M; Hiemstra C; de Waard H; Zuidema J; Steendam R; Frijlink HW; Hinrichs WL
    Int J Pharm; 2015 Mar; 480(1-2):73-83. PubMed ID: 25575472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.